BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2584354)

  • 1. The effects of RU 486 on immune function and steroid-induced immunosuppression in vitro.
    Van Voorhis BJ; Anderson DJ; Hill JA
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1195-9. PubMed ID: 2584354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects.
    Laue L; Lotze MT; Chrousos GP; Barnes K; Loriaux DL; Fleisher TA
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1474-80. PubMed ID: 2172280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cortisol, progesterone, and transcortin on phytohemagglutinin-stimulated human blood mononuclear cells and their interplay.
    Ogawa K; Sueda K; Matsui N
    J Clin Endocrinol Metab; 1983 Jan; 56(1):121-6. PubMed ID: 6847866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human lymphocyte stimulation by steroid hormones: cytokinetic mechanisms.
    Mendelsohn J; Multer MM; Bernheim JL
    Clin Exp Immunol; 1977 Jan; 27(1):127-34. PubMed ID: 849646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro response of turkey lymphocytes to steroid hormones.
    Redig PT; Dunnette JL; Mauro L; Sivanandan V; Markham F
    Avian Dis; 1985; 29(2):373-83. PubMed ID: 4026731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue and serum levels of steroid hormones and RU 486 after administration of mifepristone.
    Wang JD; Shi WL; Zhang GQ; Bai XM
    Contraception; 1994 Mar; 49(3):245-53. PubMed ID: 8200218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of progesterone and the antiprogestin RU 486 on gonadotropin secretion in the follicular phase of the menstrual cycle.
    Permezel JM; Lenton EA; Roberts I; Cooke ID
    J Clin Endocrinol Metab; 1989 May; 68(5):960-5. PubMed ID: 2497130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression by sex steroid hormones. The effect upon PHA- and PPD-stimulated lymphocytes.
    Wyle FA; Kent JR
    Clin Exp Immunol; 1977 Mar; 27(3):407-15. PubMed ID: 862230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antiprogestin RU 486 on the proliferation and metabolic activity of stromal cells separated from human endometrium.
    Bhargava-Periwal S; Farooq A; Bhargava VL; Bhatla N; Vij U; Murugesan K
    Contraception; 1996 Feb; 53(2):127-31. PubMed ID: 8838491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential actions of progesterone and cortisol on lymphocyte and monocyte interaction during lymphocyte activation--relevance to immunosuppression in pregnancy.
    Stites DP; Bugbee S; Siiteri PK
    J Reprod Immunol; 1983 Jul; 5(4):215-28. PubMed ID: 6604810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new steroid analog RU 486 inhibits glucocorticoid action in man.
    Bertagna X; Bertagna C; Luton JP; Husson JM; Girard F
    J Clin Endocrinol Metab; 1984 Jul; 59(1):25-8. PubMed ID: 6327758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of RU486 on progesterone secretion by human preovulatory granulosa cells in culture.
    Parinaud J; Perret B; Ribbes H; Vieitez G; Baulieu EE
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1534-7. PubMed ID: 2161423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiglucocorticoid RU486 downregulates the expression of interleukin-2 receptors in normal human lymphocytes.
    Antonakis N; Markogiannakis E; Theodoropoulou M; Georgoulias V; Stournaras C; Gravanis A
    J Steroid Biochem Mol Biol; 1991 Dec; 39(6):929-35. PubMed ID: 1751392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism.
    Garrel DR; Moussali R; De Oliveira A; Lesiège D; Larivière F
    J Clin Endocrinol Metab; 1995 Feb; 80(2):379-85. PubMed ID: 7888013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the antiprogestin mifepristone, in vivo, and progesterone in vitro on prolactin production by the human decidua in early pregnancy.
    Wu WX; Glasier A; Norman J; Kelly RW; Baird DT; McNeilly AS
    Hum Reprod; 1990 Jul; 5(5):627-31. PubMed ID: 2203805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transforming growth factor-beta on the production of immunoreactive insulin-like growth factor I and progesterone and on [3H]thymidine incorporation in porcine granulosa cell cultures.
    Mondschein JS; Canning SF; Hammond JM
    Endocrinology; 1988 Oct; 123(4):1970-6. PubMed ID: 3262054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of lymphocyte responsiveness by hormone used in the treatment of urologic malignancies.
    Harty JI; Catalona WJ; Gomolka DM
    J Urol; 1976 Oct; 116(4):484-8. PubMed ID: 1053340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.